NCT04503577招募中不适用
Prospective Bladder Cancer Infrastructure: an Infrastructure for Observational and Interventional Bladder Cancer Research (ProBCI)
Prospective Bladder Cancer Infrastructure Foundation23 个研究点 分布在 1 个国家目标入组 3,600 人开始时间: 2020年10月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 3,600
- 试验地点
- 23
- 主要终点
- Overall survival
研究概览
简要总结
Prospective nation-wide cohort of high-risk non-muscle-invasive, muscle-invasive and metastatic bladder cancer in the Netherlands
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Bladder cancer
- •Any stage except Ta
- •18 years or older
- •Written informed consent
排除标准
- •No exclusion criteria
- •Note: participation in ProBCI does not exclude the patient from participation in other studies.
结局指标
主要结局
Overall survival
时间窗: 10 years
Alive/death/emigrated
次要结局
- Health-related quality of life(2 years)
- Cancer-specific health-related quality of life(2 years)
- Progression-free survival(10 yeas)
- Recurrence-free survival(10 yeas)
研究者
研究点 (23)
Loading locations...
相似试验
招募中
不适用
Prospective Bladder Cancer Infrastructure - An infrastructure for observational and interventional bladder cancer research10038364bladder cancerNL-OMON54621Stichting Prospectieve Blaaskanker Infrastructuur3,500
招募中
不适用
Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer PatientsQuality of LifeBladder CancerNCT05739968National Taiwan University Hospital120
进行中（未招募）
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220
进行中（未招募）
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001819-30-ATSanochemia Pharmazeutika AG220
已完成
2 期
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon®) fluorescence cystoscopy(Hypericin PDD)C67Malignant neoplasm of bladderDRKS00003324Sanochemia Pharmazeutika AG227